WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Jan. 7, 1999--US Diagnostic Inc. (Nasdaq Small Cap:USDL) announced Thursday that it has opened a new 10,000 square foot state-of-the-art imaging center in Wilkes-Barre, Pa.
Wilkes-Barre Imaging Center ("WBIC") now occupies one of the most modern
According to Joseph A. Paul, president and chief executive officer of US Diagnostic Inc.: "This opening is another example of our long term strategy to continue to place or expand new facilities within the network of USD centers. WBIC was previously an MRI only facility that the company opened in May 1996. WBIC has proved to be one of our most successful sites for MRI procedures. The facility will have two new MRI machines to service the community, a GE 1.5 Signa and a GE Open Profile magnet. In addition, the facility has a full complement of new GE equipment for CT (ProSpeed Spiral), Ultrasound, Mammography and X-Ray."
US Diagnostic Inc. is the leading independent provider of radiology services focused on the development, acquisition, operation and management of multi-modality diagnostic imaging centers and related medical facilities in the United States. The company has locations in 18 states and owns, operates or manages 98 fixed site diagnostic imaging facilities.
Statements contained in this press release, which are not historical facts, are forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on the company's expectations and are subject to a number of risks and uncertainties, including but not limited to economic, competitive and other factors affecting the company's operations, markets and expansion strategies, adequate collection of accounts receivable, available financing, government regulations involving the company, facts and events not known at the time of this press release, and other factors discussed in the company's filings with the Securities and Exchange Commission. Many of these factors are beyond the company's control. Actual results could differ materially from the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results anticipated in the forward-looking information in this press release will, in fact, occur.